BioSpace News Archive

Within the last week, many Americans who are afflicted with chronic back pain have been informed their back surgery has been canceled due to COVID-19.

CareDx, Inc. announces that the American Journal of Transplantation published a case report from Johns Hopkins on a successful kidney retransplantation in a patient who experienced rejection of a first kidney transplant after undergoing immune-stimulating therapy for the treatment of metastatic cutaneous squamous cell carcinoma.

Oncopeptides AB announced measures the company is taking in response to the global spread of the novel coronavirus pandemic.

Revive Therapeutics Ltd., a life sciences company, is pleased to announce that it is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease.

Direct-to-consumer company to provide free, remote access to licensed hearing professionals in addition to a number of offerings to ensure those with hearing challenges can receive the help they need from the comfort of their own home by calling 1-800-885-HEAR [20-March-2020] SAN JOSE, Calif. , March 20, 2020 /PRNewswire/ -- In light of the temporary closure of hearin

Epizyme, Inc. announced that the company has appointed Jeffery Kutok, M.D., Ph.D., as chief scientific officer.

Company Says Their Technology Can Empower Network of Independent Labs to Meet COVID-19 Testing Demand

Working with CEOs of primary care associations across the country, the National Association of Community Health Centers requests immediate financial relief of between $3.2 and $3.3 billion through the federal Stimulus Bill.

UnitedHealth Group will release its first quarter 2020 financial results on Wednesday, April 15, 2020, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors.

Sorrento Therapeutics, Inc. announced it has produced a preclinical batch of the STI-4398 protein to immediately commence testing its neutralization and blocking activity in preventing SARS-CoV-2 virus from infecting ACE2-expressing cells..